Febrile plasmodium falciparum malaria 4 years after exposure in a man with sickle cell disease

Clinical Infectious Diseases

Volumn 47, Issue 4, 2008, Pages

  Greenwood, Tatiana ^a   Vikerfors, Tomas ^a   Sjöberg, Maria ^a   Skeppner, Gunnar ^a   Färnert, Anna ^b  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ATOVAQUONE PLUS PROGUANIL; CEFOTAXIME; MEFLOQUINE;

ACUTE CHEST SYNDROME; ADULT; ARTICLE; BACKACHE; BLOOD SMEAR; CASE REPORT; ELECTROCARDIOGRAPHY; ENDEMIC DISEASE; ENVIRONMENTAL EXPOSURE; FEVER; FLUID THERAPY; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INCUBATION TIME; LEUKOCYTE COUNT; MALARIA; MALE; NONCARDIAC CHEST PAIN; OXYGEN THERAPY; PARESTHESIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; SCREENING TEST; SEROLOGY; SICKLE CELL ANEMIA; SPLENOMEGALY; STOMACH PAIN; SWEATING; SWEDEN; TACHYCARDIA; THORAX RADIOGRAPHY; TOGO; TREATMENT OUTCOME; ADOLESCENT; ANIMAL; ERYTHROCYTE; MALARIA FALCIPARUM; PARASITOLOGY; PATHOPHYSIOLOGY; SICKLE CELL TRAIT; TIME; TRAVEL;

ADOLESCENT; ANIMALS; ERYTHROCYTES; FEVER; HUMANS; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; SICKLE CELL TRAIT; SWEDEN; TIME FACTORS; TRAVEL;

EID: 48749133427     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/590250     Document Type: Article

References (12)

1. Schwartz E, Parise M, Kozarsky P, Cetron M. Delayed onset of malaria - implications for chemoprophylaxis in travelers. N Engl J Med 2003; 349:1510-6.
2. Collins WE, Jeffery GM. A retrospective examination of secondary sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity following secondary infection. Am J Trop Med Hyg 1999; 61:20-35.
3. Snounou G, Viriyakosol S, Zhu XP, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 1993; 61:315-20.
4. Mungai M, Tegtmeier G, Chamberland M, Parise M. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med 2001; 344:1973-8.
5. Food and Drug Administration memorandum. Recommendations for deferral of donors for malaria risk. July 26, 1994. Available at: http://www.fda.gov/cber/bldmem/072694.pdf. Accessed 12 November 2007.
6. Williams TN. Human red blood cell polymorphisms and malaria. Curr Opin Microbiol 2006; 9:388-94.
7. Bidegain F, Berry A, Alvarez M, et al. Acute Plasmodium falciparum malaria following splenectomy for suspected lymphoma in 2 patients. Clin Infect Dis 2005; 40:e97-100.
8. Bull PC, Lowe BS, Kortok M, Molyneux CS, Newbold CI, Marsh K. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat Med 1998; 4:358-60.
9. David PH, Hommel M, Miller LH, Udeinya IJ, Oligino LD. Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes. Proc Natl Acad Sci U S A 1983; 80:5075-9.
10. Landau I, Chabaud AG, Mora-Silvera E, et al. Survival of rodent malaria merozoites in the lymphatic network: potential role in chronicity of the infection. Parasite 1999; 6:311-22.
11. Muehlenbachs A, Mutabingwa TK, Fried M, Duffy PE. An unusual presentation of placental malaria: a single persisting nidus of sequestered parasites. Hum Pathol 2007; 38:520-3.
12. Thapar MM, Gil JP, Björkman A. In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil. Trans R Soc Trop Med Hyg 2005; 99:62-70.